Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | 828,000 | reported | 12 Dec 2025 | tx 19+3,294,242−254,624 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Dec 2025 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 828,000 | 0.00 USD | deriv |
| 05 Nov 2025 | PURCHASE | RELMADA THERAPEUTICS, INC. | 136,000 | 2.20 USD | |
| 26 Jun 2025 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 400,000 | 0.00 USD | deriv |
| 16 May 2025 | PURCHASE | RELMADA THERAPEUTICS, INC. | 228,961 | 0.45 USD | first after silence |
| 24 May 2024 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 54,624 | 0.00 USD | deriv |
| 24 May 2024 | OTHER | RELMADA THERAPEUTICS, INC. | 54,624 | 0.00 USD | deriv |
| 31 Jan 2024 | PURCHASE | RELMADA THERAPEUTICS, INC. | 13,670 | 4.05 USD | |
| 30 Jan 2024 | PURCHASE | RELMADA THERAPEUTICS, INC. | 14,500 | 3.87 USD | |
| 29 Jan 2024 | PURCHASE | RELMADA THERAPEUTICS, INC. | 10,800 | 3.65 USD | |
| 15 Dec 2023 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 82,090 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 321,238 | 0.00 USD | deriv |
| 16 Dec 2022 | OTHER | RELMADA THERAPEUTICS, INC. | 200,000 | — | deriv |
| 16 Dec 2022 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 197,123 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 295,404 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 200,000 | 0.00 USD | deriv |
| 17 Dec 2021 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 226,832 | 0.00 USD | deriv |
| 07 Jan 2021 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 112,500 | 0.00 USD | deriv |
| 07 Jan 2021 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 112,500 | 0.00 USD | deriv |
| 19 Dec 2019 | GRANT_AWARD | RELMADA THERAPEUTICS, INC. | 60,000 | 43.47 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 May 2025.